Share your insights

Help us by sharing what content you've recieved in your exams


Myocardial infarction

Background knowledge ๐Ÿง 

Definition

  • Myocardial infarction (MI) refers to the irreversible necrosis of heart muscle secondary to prolonged ischemia.
  • Commonly known as a heart attack.
  • Usually results from the rupture of an atherosclerotic plaque in a coronary artery.

Epidemiology

  • MI is a leading cause of death worldwide, particularly in developed countries.
  • In the UK, over 100,000 hospital admissions occur annually due to MI.
  • Incidence increases with age; higher in men compared to women.
  • Mortality rates have decreased due to improved treatments.

Aetiology and Pathophysiology

  • Most commonly caused by atherosclerosis of coronary arteries.
  • Rupture of plaque leads to thrombus formation, occluding the artery.
  • Can also be caused by coronary artery spasm or embolism.
  • Ischemia leads to myocardial cell death, triggering an inflammatory response.
  • Extent of damage depends on the duration and area of the occlusion.

Types

  • ST-segment Elevation Myocardial Infarction (STEMI): Complete occlusion of a coronary artery.
  • Non-ST-segment Elevation Myocardial Infarction (NSTEMI): Partial occlusion or distal embolization.
  • Type 1 MI: Spontaneous due to a primary coronary event.
  • Type 2 MI: Secondary to ischemic imbalance (e.g., due to increased demand or decreased supply).

Clinical Features ๐ŸŒก๏ธ

Symptoms

  • Central chest pain, often described as a heavy, crushing, or tight sensation.
  • Pain radiating to the left arm, neck, jaw, or back.
  • Associated symptoms: sweating, nausea, vomiting, and shortness of breath.
  • May present atypically in diabetics, elderly, or women (e.g., epigastric pain, dyspnea).
  • Sudden cardiac death can be the first presentation in some cases.

Signs

  • Pallor and sweating.
  • Tachycardia or bradycardia.
  • Hypotension or hypertension.
  • S4 gallop due to stiff ventricles.
  • Signs of heart failure (e.g., raised JVP, lung crackles).
  • New heart murmurs (e.g., mitral regurgitation due to papillary muscle dysfunction).

Investigations ๐Ÿงช

Tests

  • ECG: ST-segment elevation, T-wave inversion, or new LBBB in STEMI; ST-segment depression in NSTEMI.
  • Cardiac biomarkers: Troponin I/T (elevated in MI), CK-MB (less specific).
  • Chest X-ray: To rule out differential diagnoses like aortic dissection, pulmonary edema.
  • Echocardiography: Assess wall motion abnormalities, ejection fraction.
  • Coronary angiography: Gold standard for identifying and treating coronary occlusions.

Management ๐Ÿฅผ

Acute Management

  • Immediate: MONA – Morphine, Oxygen (if hypoxic), Nitroglycerin, Aspirin.
  • Antiplatelet therapy: Dual antiplatelet therapy (Aspirin + P2Y12 inhibitor).
  • Anticoagulation: Unfractionated heparin or LMWH.
  • Reperfusion therapy: Primary PCI for STEMI within 120 minutes; fibrinolysis if PCI not available.
  • NSTEMI: Risk stratification to guide early invasive vs. conservative approach.

Long-term Management

  • Lifestyle modification: Smoking cessation, diet, exercise.
  • Pharmacotherapy: Beta-blockers, ACE inhibitors, statins, dual antiplatelet therapy (for 12 months).
  • Monitoring: Regular follow-ups, echocardiography to assess cardiac function.
  • Secondary prevention: Manage comorbidities (hypertension, diabetes).

Complications

  • Arrhythmias: Ventricular fibrillation, atrial fibrillation.
  • Heart failure: Due to extensive myocardial damage.
  • Cardiogenic shock: Severe LV dysfunction.
  • Mechanical complications: Papillary muscle rupture, ventricular septal defect.
  • Pericarditis: Early (within days) or Dressler’s syndrome (weeks later).

Prognosis

  • Depends on the extent of myocardial damage and promptness of treatment.
  • Mortality is highest within the first 30 days, particularly in STEMI.
  • Long-term outcomes improve with adherence to medical therapy and lifestyle changes.
  • Risk of recurrent MI or heart failure increases if risk factors are not controlled.

Key Points

  • Early recognition and treatment of MI are crucial for reducing mortality and morbidity.
  • STEMI requires urgent reperfusion therapy, ideally PCI.
  • NSTEMI management depends on risk stratification and may involve PCI or conservative treatment.
  • Secondary prevention and lifestyle modification are key to improving long-term outcomes.

No comments yet ๐Ÿ˜‰

Leave a Reply